These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 20516129)

  • 1. The origins and evolution of the p53 family of genes.
    Belyi VA; Ak P; Markert E; Wang H; Hu W; Puzio-Kuter A; Levine AJ
    Cold Spring Harb Perspect Biol; 2010 Jun; 2(6):a001198. PubMed ID: 20516129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of MDM2 family genes.
    Momand J; Villegas A; Belyi VA
    Gene; 2011 Oct; 486(1-2):23-30. PubMed ID: 21762762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of p53 gene family in reproduction.
    Hu W
    Cold Spring Harb Perspect Biol; 2009 Dec; 1(6):a001073. PubMed ID: 20457559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63/p73 in the control of cell cycle and cell death.
    Allocati N; Di Ilio C; De Laurenzi V
    Exp Cell Res; 2012 Jul; 318(11):1285-90. PubMed ID: 22326462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyoxalase II, a detoxifying enzyme of glycolysis byproduct methylglyoxal and a target of p63 and p73, is a pro-survival factor of the p53 family.
    Xu Y; Chen X
    J Biol Chem; 2006 Sep; 281(36):26702-13. PubMed ID: 16831876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservation of DNA-binding specificity and oligomerisation properties within the p53 family.
    Brandt T; Petrovich M; Joerger AC; Veprintsev DB
    BMC Genomics; 2009 Dec; 10():628. PubMed ID: 20030809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dominant-negative interplay between p53, p63 and p73: A family affair.
    Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
    Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to cancer treatment using structural hybrids of the p53 gene family.
    Sasaki Y; Oshima Y; Koyama R; Tamura M; Kashima L; Idogawa M; Yamashita T; Toyota M; Imai K; Shinomura Y; Tokino T
    Cancer Gene Ther; 2012 Nov; 19(11):749-56. PubMed ID: 22956039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 family: at the crossroads in cancer therapy.
    Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
    Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes.
    Lefkimmiatis K; Caratozzolo MF; Merlo P; D'Erchia AM; Navarro B; Levrero M; Sbisa' E; Tullo A
    Cancer Res; 2009 Nov; 69(22):8563-71. PubMed ID: 19861536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Diversification after Gene Duplication: Paralog Specific Regions of Structural Disorder and Phosphorylation in p53, p63, and p73.
    Dos Santos HG; Nunez-Castilla J; Siltberg-Liberles J
    PLoS One; 2016; 11(3):e0151961. PubMed ID: 27003913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diversification and complex evolutionary history of the p53 tumor suppressor gene family.
    Nedelcu AM; Tan C
    Dev Genes Evol; 2007 Dec; 217(11-12):801-6. PubMed ID: 17924139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
    Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
    Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cadmium, cobalt and nickel on sequence-specific DNA binding of p63 and p73 in vitro and in cells.
    Adámik M; Bažantová P; Navrátilová L; Polášková A; Pečinka P; Holaňová L; Tichý V; Brázdová M
    Biochem Biophys Res Commun; 2015 Jan; 456(1):29-34. PubMed ID: 25446071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
    Vilgelm A; El-Rifai W; Zaika A
    Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox state of p63 and p73 core domains regulates sequence-specific DNA binding.
    Tichý V; Navrátilová L; Adámik M; Fojta M; Brázdová M
    Biochem Biophys Res Commun; 2013 Apr; 433(4):445-9. PubMed ID: 23501101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.
    Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK
    Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.